Evotec SE (EVO) Other Accumulated Expenses (2009 - 2026)
Evotec SE's (EVO) quarterly Other Accumulated Expenses came in at $32.1 million in Q2 2026, up 12.02% year-over-year from $28.6 million in Q2 2025, and up 10.38% quarter-over-quarter from $29.1 million in Q1 2026.
Analysis
Evotec SE (EVO) Other Accumulated Expenses (2009 - 2026) Analysis & Trends
Evotec SE has disclosed Other Accumulated Expenses across 9 years of filings, most recently posting $32.1 million for Q2 2026.
- In Q2 2026, Other Accumulated Expenses rose 12.02% year-over-year to $32.1 million; the TTM figure through Jun 2026 stood at $32.1 million (up 12.02% YoY), while the FY2025 annual figure was $24.2 million, down 18.6% from the prior year.
- Other Accumulated Expenses came in at $32.1 million for Q2 2026 at Evotec SE, up from $29.1 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $32.7 million in Q3 2025 to a low of $12.0 million in Q1 2022.
- Average Other Accumulated Expenses over 5 years is $24.9 million, with a median of $26.2 million recorded in 2024.
- Year-over-year, Other Accumulated Expenses decreased 28.48% in 2022 and soared 40.9% in 2023.
- Over 5 years, Other Accumulated Expenses stood at $17.2 million in 2022, then soared by 40.9% to $24.3 million in 2023, then increased by 20.76% to $29.3 million in 2024, then decreased by 15.06% to $24.9 million in 2025, then increased by 28.79% to $32.1 million in 2026.
- Per Business Quant data, the three most recent Other Accumulated Expenses figures were $32.1 million in Q2 2026, $29.1 million in Q1 2026, and $24.9 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32.08 Mn |
| Mar 31, 2026 | 29.07 Mn |
| Dec 31, 2025 | 24.91 Mn |
| Sep 30, 2025 | 32.67 Mn |
| Jun 30, 2025 | 28.64 Mn |
| Mar 31, 2025 | 29.22 Mn |
| Dec 31, 2024 | 29.33 Mn |
| Sep 30, 2024 | 26.25 Mn |
| Dec 31, 2023 | 24.29 Mn |
| Jun 30, 2023 | 23.15 Mn |
| Dec 31, 2022 | 17.24 Mn |
| Sep 30, 2022 | 14.78 Mn |
| Mar 31, 2022 | 11.98 Mn |
| Dec 31, 2021 | 14.37 Mn |
| Sep 30, 2021 | 20.67 Mn |
| Dec 31, 2020 | 23.90 Mn |
| Sep 30, 2010 | 366,721.43 |
| Jun 30, 2010 | 1.50 Mn |
| Mar 31, 2010 | 1.30 Mn |
| Dec 31, 2009 | 1.03 Mn |